Cytomegalovirus Infection in Seronegative Patients Treated With Prophylaxis: Case-Controlled Study

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2231-2232

  Moreno de la Higuera Diaz M A ^a   Calvo Romero, N ^a   Sanchez Fructuoso A ^a   Conesa, J ^a   Marques Vidas, M ^a   Prats, D ^a   Barrientos Guzman A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY; SURVIVAL;

ANTIVIRAL AGENTS; BLOOD TRANSFUSION; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 34548679367     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.07.074     Document Type: Article

References (5)

1. Opelz G., Dohler B., and Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 (2004) 928
2. Akalin E., Sehgal V., Ames S., et al. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 3 (2003) 731
3. Leroy F., Sechet A., Abou Ayache R., et al. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients. Transplant Proc 38 (2006) 2324
4. Pescovitz M.D. Benefits of cytomegalovirus prophylaxis in solid organ transplantation. Transplantation 82 2 suppl (2006) S4
5. Snydman D.R. The case for cytomegalovirus prophylaxis in solid organ transplantation. Rev Med Virol 16 (2006) 289